Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Bishop

Showing results (11-20 of 201) with videos related to

Pageof 21
Sort By:
Current Opinion in Pharmacology|December 6, 2008
Tumour vascularisation: a druggable targetDavid Bishop-Bailey
PPAR Research|April 3, 2008
A Role for PPARbeta/delta in Ocular AngiogenesisDavid Bishop-Bailey
Current Opinion in Investigational Drugs (London, England : 2000)|February 24, 2010
PPAR receptor activation: Experimental studies on cardiac structure and functionDavid Bishop-Bailey
Current Atherosclerosis Reports|March 17, 2015
Nuclear receptors in vascular biologyDavid Bishop-Bailey
Biochemical Society Transactions|November 23, 2011
PPARs and angiogenesisDavid Bishop-Bailey
Drug News & Perspectives|December 18, 2004
FXR as a novel therapeutic target for vascular diseaseDavid Bishop-Bailey
Sports Medicine (Auckland, N.Z.)|March 26, 2009
Muscle fatigue in males and females during multiple-sprint exerciseFrançois Billaut, David Bishop
Medicine and Science in Sports and Exercise|May 5, 2005
Effects of induced metabolic alkalosis on prolonged intermittent-sprint performanceDavid Bishop, Brett Claudius
European Journal of Applied Physiology|July 1, 2010
Combined cycle and run performance is maximised when the cycle is completed at the highest sustainable intensityRobert Suriano, David Bishop
European Journal of Applied Physiology|April 14, 2006
Determinants of repeated-sprint ability in females matched for single-sprint performanceDavid Bishop, Johann Edge
Pageof 21

Showing results (11-20 of 201) with videos related to

Sort By:
Pageof 21
Current Opinion in Pharmacology|December 6, 2008
Tumour vascularisation: a druggable targetDavid Bishop-Bailey
PPAR Research|April 3, 2008
A Role for PPARbeta/delta in Ocular AngiogenesisDavid Bishop-Bailey
Current Opinion in Investigational Drugs (London, England : 2000)|February 24, 2010
PPAR receptor activation: Experimental studies on cardiac structure and functionDavid Bishop-Bailey
Current Atherosclerosis Reports|March 17, 2015
Nuclear receptors in vascular biologyDavid Bishop-Bailey
Biochemical Society Transactions|November 23, 2011
PPARs and angiogenesisDavid Bishop-Bailey
Drug News & Perspectives|December 18, 2004
FXR as a novel therapeutic target for vascular diseaseDavid Bishop-Bailey
Sports Medicine (Auckland, N.Z.)|March 26, 2009
Muscle fatigue in males and females during multiple-sprint exerciseFrançois Billaut, David Bishop
Medicine and Science in Sports and Exercise|May 5, 2005
Effects of induced metabolic alkalosis on prolonged intermittent-sprint performanceDavid Bishop, Brett Claudius
European Journal of Applied Physiology|July 1, 2010
Combined cycle and run performance is maximised when the cycle is completed at the highest sustainable intensityRobert Suriano, David Bishop
European Journal of Applied Physiology|April 14, 2006
Determinants of repeated-sprint ability in females matched for single-sprint performanceDavid Bishop, Johann Edge
Pageof 21